Application value of prostate-specific antigen density combined with multiparametric MRI in early diagnosis of prostate cancer
Magnetic Resonance Imaging · 2026
DOI: 10.1016/j.mri.2025.110593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance Imaging, 2026. Verfasst von Di Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Prostate-Specific Antigen, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Diagnosis of prostate cancer in the PSA gray zone (4-10 ng/mL) and PI-RADS 3 cases remains challenging. Although multiparametric MRI (mpMRI) is widely used, its diagnostic accuracy is limited by inter-reader variability and the lack of integration with clinical indicators. Prostate-specific antigen density (PSAD) is a valuable risk stratifier, but its optimal combination with mpMRI remains unclear. METHODS: We developed a deep-learning model that integrates PSAD with mpMRI-including T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and apparent diffusion coefficient (ADC) maps derived from DWI. A cross-modal attention-guided (CM-AG) fusion module weights the PSAD and mpMRI feature branches. Performance was assessed in the PSA gray zone and the PI-RADS 3 subgroup. Ablation experiments quantified the incremental contributions of PSAD and CM-AG. RESULTS: The model achieved AUC = 0.89 in the PSA gray-zone cohort and AUC = 0.83 in PI-RADS 3, outperforming single-modality MRI baselines and PI-RADS-based assessment alone (DeLong p < 0.01). In patients with larger prostate volumes, specificity increased by 10.2 %. Ablation results confirmed that both PSAD and CM-AG contributed materially to performance gains. CONCLUSION: Fusing PSAD with mpMRI via cross-modal attention improves diagnostic performance, particularly in challenging subgroups (PSA gray zone, PI-RADS 3). This approach may support more consistent risk stratification and earlier detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: tangzhaobing1127@163.com.
Zitieren
APA
Wu, D., & Tang, Z. (2026). Application value of prostate-specific antigen density combined with multiparametric MRI in early diagnosis of prostate cancer. Magnetic Resonance Imaging. https://doi.org/10.1016/j.mri.2025.110593
Vancouver
Wu D, Tang Z. Application value of prostate-specific antigen density combined with multiparametric MRI in early diagnosis of prostate cancer. Magnetic Resonance Imaging. 2026. doi:10.1016/j.mri.2025.110593
BibTeX
@article{Wu2026,
author = {Wu, Di and Tang, Zhaobing},
title = {Application value of prostate-specific antigen density combined with multiparametric MRI in early diagnosis of prostate cancer},
journal = {Magnetic Resonance Imaging},
year = {2026},
doi = {10.1016/j.mri.2025.110593}
}
EUVIMED